Declining Stock and Decent Financials: Is The Market Wrong About Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH)?

Simply Wall StMar 3 07:25 ET

Results: Aurinia Pharmaceuticals Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates

Yahoo FinanceMar 2 07:36 ET

RBC Capital Maintains Aurinia Pharmaceuticals(AUPH.US) With Buy Rating, Cuts Target Price to $8

Moomoo NewsFeb 28 07:31 ET · Ratings

RBC Lowers Price Target on Aurinia Pharmaceuticals to $8 From $9, Keeps Outperform, Speculative Risk

MT NewswiresFeb 28 07:10 ET · Ratings

Regulatory and Financial Challenges Loom for Aurinia Pharmaceuticals Despite FDA and EC Approvals

TipRanksFeb 28 01:00 ET

Aurinia Pharmaceuticals Reports Strong 2024 Financial Growth

TipRanksFeb 27 23:54 ET